12 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19062157 | IMAGE ENCODING/DECODING METHOD AND APPARATUS USING INTRA-SCREEN PREDICTION | MAHMUD, FARHAN | 2483 | Non-Final OA | Feb 25, 2025 |
| 18827881 | DISPLAY APPARATUS INCLUDING FIRST, SECOND AND THIRD TRANSISTORS, AND METHOD OF DRIVING THE SAME | LIN, CHUN-NAN | 2629 | Non-Final OA | Sep 09, 2024 |
| 18609871 | MEMORY DEVICE BASED ON IGO CHANNEL LAYER AND METHOD OF FABRICATING THE SAME | WALL, VINCENT | 2898 | Final Rejection | Mar 19, 2024 |
| 18417235 | LOCALIZATION METHOD AND APPARATUS USING LINE CLOUD MAP DATA, LINE CLOUD MAP DATA GENERATION METHOD | WILBURN, MOLLY K | 2666 | Non-Final OA | Jan 19, 2024 |
| 18385252 | MXENE COMPOSITE FIBERS AND MANUFACTURING METHOD THEREOF | CHOI, PETER Y | 1786 | Final Rejection | Oct 30, 2023 |
| 18309697 | BIOMARKER FOR HER2-POSITIVE CANCER AND ANTI-HER2 THERAPY AND APPLICATIONS THEREOF | AEDER, SEAN E | 1642 | Final Rejection | Apr 28, 2023 |
| 17898991 | METHOD AND DEVICE FOR SYNTHESIZING MULTI-SPEAKER SPEECH USING ADVERSARIAL ARTIFICIAL NEURAL NETWORK | DORVIL, RICHEMOND | 2658 | Non-Final OA | Aug 30, 2022 |
| 17797275 | UNSATURATED FATTY ACID-CONJUGATED CP2C-TARGETING PEPTIDE-BASED ANTICANCER AGENT | BEANE, RANDALL L | 1654 | Final Rejection | Aug 03, 2022 |
| 17622893 | THREE-DIMENSIONAL NEUROMORPHIC DEVICE HAVING MULTIPLE SYNAPSES PER NEURON | DASGUPTA, SHOURJO | 2144 | Final Rejection | Dec 27, 2021 |
| 17608548 | SAMPLE ANALYSIS METHOD AND DEVICE BASED ON KERNEL MODULE IN GENOMIC MODULE NETWORK | BICKHAM, DAWN MARIE | 1685 | Final Rejection | Nov 03, 2021 |
| 17272383 | DETECTION METHOD AND DETECTION APPARATUS FOR GENOMIC STRUCTURAL VARIATIONS BASED ON K-MER SET IN REFERENCE GENOME | PULLIAM, JOSEPH CONSTANTINE | 1687 | Final Rejection | Mar 01, 2021 |
| 16931624 | LATENT HEAT STORAGE COMPOSITE HAVING NETWORK OF PROTECTIVE NANOSTRUCTURES | CORALLO, CATRIONA MARY | 1732 | Final Rejection | Jul 17, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial